- Issuer ticker
-
TLSI
- Reported as of
-
05 Oct 2026
- Net transaction value
-
-$1,387
- SEC form
-
4
- Accepted by SEC
-
07 Oct 2026, 16:02:37 UTC
Filing notes and source
Key filing fact
Jennifer Stevens filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 07 Oct 2026.
Key facts
- This page summarizes Jennifer Stevens's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Oct 2026, 16:02.
Change
- Previous filing in this sequence was filed on 20 Mar 2026.
- Current net transaction value: -$1,387.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001982621
Primary reporting owner
Stevens Jennifer
- Relationship
-
Chief Regulatory Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSI
transaction
Common Stock
Sale
- Transaction value
- -$1,387
- Shares
- -316
- Change %
- -0.25%
- Price
-
$4.39
- Shares after
- 123,794
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote